JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szolnoki, Z
Right arrow Articles by Melegh, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szolnoki, Z
Right arrow Articles by Melegh, B
Related Collections
Right arrow Genetics
Right arrow Ischemic heart disease
Right arrow Hypertension
Journal of Neurology Neurosurgery and Psychiatry 2003;74:1615-1620
© 2003 BMJ Publishing Group Ltd


PAPER

Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke

Z Szolnoki1, F Somogyvári2, A Kondacs1, M Szabó1, L Fodor2, J Bene3, B Melegh3

1 Department of Neurology and Neurophysiology, Pándy Kálmán County Hospital, Gyula, Hungary
2 Central Laboratory, Pándy Kálmán County Hospital, Gyula, Hungary
3 MTA-PTE Clinical Genetics Research Group of Hungarian Academy of Sciences, Department of Medical Genetics and Child Development, University of Pécs, Hungary

Correspondence to:
Correspondence to:
Dr Z Szolnoki
H-5600 Békéscsaba, Pipacs köz 9, Hungary; szolnoki99{at}hotmail.com

Objectives: Ischaemic stroke is a frequent heterogeneous multifactorial disease that is affected by a number of genetic mutations and environmental factors. We hypothesised the clinical importance of the interactions between common, unfavourable genetic mutations and clinical risk factors in the development of ischaemic stroke.

Methods: The Factor V Leiden G1691A (Leiden V), the prothrombin G20210A, the methylenetetrahydrofolate reductase C677T (MTHFR C677T) mutations, the angiotensin converting enzyme I/D (ACE I/D), and apolipoprotein allele e4 (APO e4) genotypes were examined by the polymerase chain reaction (PCR) technique in 867 ischaemic stroke patients and 743 healthy controls. Logistic regression models were used to estimate the roles of the co-occurrences of the clinical risk factors and common genetic mutations in ischaemic stroke.

Results: The Leiden V mutation in combination with hypertension or diabetes mellitus increased the risk of ischaemic stroke. We found synergistic effects between the ACE D/D and MTHFR 677TT genotypes and drinking or smoking. The presence of the APO e4 greatly facilitated the unfavourable effects of hypertension, diabetes mellitus, smoking, or drinking on the incidence of ischaemic stroke.

Conclusion: In certain combinations, pairing of common unfavourable genetic factors, which alone confer only minor or non-significant risk, with clinical risk factors can greatly increase the susceptibility to ischaemic stroke.


Keywords: genetics; interactions; modifying effect

Abbreviations: ACE, angiotensin converting enzyme; PCR, polymerase chain reaction; MRI, magnetic resonance imaging; CT, computerised tomography; TIA, transient ischaemic attack; EGC, electrocardiogram; BMI, body mass index; EDTA, ethylene diamine tetra-acetic acid; OR, odds ratio; CI, confidence interval




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
M. Folstein, T. Liu, I. Peter, J. Buel, L. Arsenault, T. Scott, and W. W. Qiu
The Homocysteine Hypothesis of Depression
Am J Psychiatry, June 1, 2007; 164(6): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
D. Eterovic, M. Titlic, V. Culic, R. Zadro, and D. Primorac
Lower Contribution of Factor V Leiden or G202104 Mutations to Ischemic Stroke in Patients With Clinical Risk Factors: Pair-Matched Case-Control Study
Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 188 - 193.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
C. J. Glueck, N. Goldenberg, H. Bell, K. Golnik, and P. Wang
Amaurosis Fugax: Associations with Heritable Thrombophilia
Clinical and Applied Thrombosis/Hemostasis, July 1, 2005; 11(3): 235 - 241.
[Abstract] [PDF]


Home page
StrokeHome page
S. Cronin, K. L. Furie, and P. J. Kelly
Dose-Related Association of MTHFR 677T Allele With Risk of Ischemic Stroke: Evidence From a Cumulative Meta-Analysis
Stroke, July 1, 2005; 36(7): 1581 - 1587.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Pezzini, M. Grassi, E. D. Zotto, S. Archetti, R. Spezi, V. Vergani, D. Assanelli, L. Caimi, and A. Padovani
Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults
Stroke, March 1, 2005; 36(3): 533 - 539.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.